AEs enhanced breast cancer sensitivity to PTX by decreasing cell proliferation both through the ROS/Nrf2 pathway and via the downregulation of p-ERK, and these mechanisms resulted in the decrease in FEN1 expression leading to DNA damage accumulation and DNA replication reduction. The gene discussed is FEN1; the disease is breast cancer.